LifeSci Capital analyst Gaurav Maini downgraded Sionna Therapeutics (NASDAQ: SION) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Sionna Therapeutics click here. For more ratings news on Sionna Therapeutics click here.

Shares of Sionna Therapeutics closed at $51.04 yesterday.